Taipei, Taiwan

Gholam H Hakimelahi

This inventor holds 5 USPTO granted patents. Top assignees: National Science Council, Academia Sinica. Active years: 1998-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gholam H Hakimelahi. Retrieved from https://idiyas.com/inventor/gholam-h-hakimelahi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 80.0

Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 1998-2004

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Gholam H Hakimelahi: Innovator in Antiviral Compounds

Introduction

Gholam H Hakimelahi is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of antiviral compounds, holding a total of 5 patents. His work focuses on developing innovative antibacterial agents that have the potential to impact public health positively.

Latest Patents

Among his latest patents, Gholam has synthesized a series of phloroglucide derivatives that exhibit potent antibacterial activities. These include unsymmetrical phloroglucide analogs and phloroglucides attached to cephalosporins at the C-3′ position. Additionally, he has developed 7-(phloroglucidamido)cephalosporins, which further enhance the efficacy of antibacterial treatments.

Career Highlights

Gholam has worked with esteemed organizations such as the National Science Council and Academia Sinica. His research has been pivotal in advancing the understanding of antiviral compounds and their applications in medicine.

Collaborations

He has collaborated with notable colleagues, including Jih Ru Hwu and Shwu-Chen Tsay, to further his research and development efforts in the field.

Conclusion

Gholam H Hakimelahi's innovative work in antiviral compounds showcases his dedication to improving healthcare through scientific research. His contributions continue to pave the way for advancements in antibacterial agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…